Hoffmann-La Roche
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 9
- Cancer Diagnosis and Treatment 3
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Pierre Canal (2 shared papers)A. Pujol (2 shared papers)Étienne Chatelut (2 shared papers)Georges Houin (2 shared papers)R. Bugat (2 shared papers)A Boneu (2 shared papers)Christine Chevreau (1 shared paper)D. Serin (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (3 papers)JNCI Journal of the National Cancer Institute (1 paper)European Journal of Cancer (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- FranceBelgiumSwitzerland
In The Last Decade
Hoffmann-La Roche
15 papers receiving 439 citations
Peers
Comparison fields: 5 of 59
- Oncology 201
- Cancer Research 105
- Pathology and Forensic Medicine 101
- Genetics 114
- Pharmacology 22
Countries citing papers authored by Hoffmann-La Roche
This map shows the geographic impact of Hoffmann-La Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoffmann-La Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoffmann-La Roche more than expected).
Fields of papers citing papers by Hoffmann-La Roche
This network shows the impact of papers produced by Hoffmann-La Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoffmann-La Roche. The network helps show where Hoffmann-La Roche may publish in the future.
Co-authors
The 25 scholars most cited alongside Hoffmann-La Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 202 | |
| 2 | 1997 | 123 | |
| 3 | 2009 | 39 | |
| 4 | 2009 | 34 | |
| 5 | In vivo measurement of transepidermal water loss | 1978 | 18 |
| 6 | 1996 | 14 | |
| 7 | 2010 | 8 | |
| 8 | Combined results of 4 phase I and pharmacokinetic (PK) studies of E7070, a novel chloroindolyl-sulphonamide inhibiting the activation of cdk2 and cyclin E | 2000 | 7 |
| 9 | 2007 | 5 | |
| 10 | 2007 | 5 | |
| 11 | [Prediction of carboplatin clearance from morphological and biological patient characteristics]. | 1995 | 4 |
| 12 | 2006 | 3 | |
| 13 | 2009 | 2 | |
| 14 | 1997 | 2 | |
| 15 | 2008 | 2 |
About Hoffmann-La Roche
Hoffmann-La Roche is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Pharmaceutical Science, having authored 15 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (7 papers), Cancer Diagnosis and Treatment (3 papers), Estrogen and related hormone effects (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Advanced Breast Cancer Therapies (2 papers), Health, Medicine and Society (1 paper) and Sympathectomy and Hyperhidrosis Treatments (1 paper). The work is most often cited by research in Oncology (201 citations), Cancer Research (105 citations), Pathology and Forensic Medicine (101 citations), Genetics (114 citations) and Pharmacology (22 citations). Hoffmann-La Roche has collaborated with scholars based in France, Belgium and Switzerland. Frequent co-authors include Pierre Canal, A. Pujol, Étienne Chatelut, Georges Houin, R. Bugat, A Boneu, Christine Chevreau, D. Serin, Silvana Lanzalone and E. Di Salle. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, JNCI Journal of the National Cancer Institute, European Journal of Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.